Clinical Trial Update: Biological, Prospective Study Evaluating the Dosage of Plasma Cytokines Including the FLT3 Ligand and IL6 of Patients Treated With Non-intensive Chemotherapy

View source ↗

Summary

This clinical trial aims to prospectively evaluate plasma cytokine levels, including FLT3 ligand and IL-6, in patients with acute myeloid leukemia, myelodysplas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Syndromes
• Myelomonocytic Leukemia

Snippet

Sponsor: Nantes University Hospital | Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndromes | Status: RECRUITING